Psychiatrists need to carry out more physical health checks for metabolic complications, says systematic review

measuring blood pressure

A new systematic review conducted by a research team from Leicester suggests that psychiatrists are failing to carry out physical health checks for metabolic complications common in patients with mental illness, in particular those who are prescribed antipsychotics.

Many hospitals now have guidelines in place to ensure that patients on antipsychotics are monitored to check blood pressure, triglycerides, cholesterol, weight gain, glucose, lipids and glycosylated haemoglobin.

This systematic review and meta analysis identified studies examining routine metabolic screening practices in patients taking antipsychotics before and following the implementation of monitoring guidelines. They identified 48 relevant studies (involving over 290,000 patients in 5 countries):

  • 39 studies focused on routine monitoring before guidelines were issued
  • 9 reported post-guideline monitoring (7 compared changes in screening practices before and after guideline implementation)

In the 39 studies that evaluated monitoring in the absence of specific guidelines, they found monitoring levels to be well below the desired level:

  • Blood pressure was monitored in 69% of patients
  • Triglycerides 60%
  • Cholesterol 42%
  • Weight gain 48%
  • Glucose 44%
  • Lipids and glycosylated haemoglobin <25%)

Similar results were seen for US and UK studies and for inpatients and outpatients.

In the 7 studies that compared rates of monitoring in the same sample of patients before and after introduction of guidelines, only data on glucose monitoring were adequate for analysis. These showed that the overall rate of glucose testing rose from 32.8% to 48.2% after guidelines were introduced (relative risk 1.47; 95% CI 1.13 to 1.9).

The authors concluded:

In routine clinical practice, metabolic monitoring is concerningly low in people prescribed antipsychotic medication. Although guidelines can increase monitoring, most patients still do not receive adequate testing.

Mitchell AJ, Delaffon V, Vancampfort D, Correll CU, De Hert M. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med. 2011 Aug 10:1-23. [Epub ahead of print] [PubMed abstract]

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Andre Tomlin

Andre Tomlin

André Tomlin is an Information Scientist with 20 years experience working in evidence-based healthcare. He's worked in the NHS, for Oxford University and since 2002 as Managing Director of Minervation Ltd, a consultancy company who do clever digital stuff for charities, universities and the public sector. Most recently André has been the driving force behind the Mental Elf and the National Elf Service; an innovative digital platform that helps professionals keep up to date with simple, clear and engaging summaries of evidence-based research. André is a Trustee at the Centre for Mental Health and an Honorary Research Fellow at University College London Division of Psychiatry. He lives in Bristol with his wife, dog and three little elflings.

More posts - Website

Follow me here –